As our Numerof 2024 U.S. Health Insurance Outlook infographic illustrates, the story for health insurance continues to be about dramatically changing roles and relationships. Payers will continue to engage in new and different ways with providers, consumers, employers, regulators, medical device makers and pharmaceutical manufacturers. All this will come in…
As our 2024 Global Medical Device Outlook infographic illustrates, medical device manufacturers face a broad array of market challenges in 2024. That said, the global outlook for the industry is positive, with growth projections ranging from 5-7% CAGR over the next five years. Background trends offer both opportunities and threats,…
What’s coming for the healthcare sector in 2024, and more importantly, what do pharma, medical device, and healthcare delivery executives need to do to succeed?
With the May 2023 expiration of the public health emergency (PHE) in the U.S., the page was turned on the pandemic. But the aftereffects remain. Staffing shortages are endemic, right up to and including physicians; staff dissatisfaction is at historic levels, leading to large scale labor disputes and nurses seeking…
As our Numerof 2024 Global Pharma Outlook infographic illustrates, this year’s story for pharmaceutical manufacturers will be about responding to growing pressure on price from government payers, and to the increasing complexity and power of a consolidating yet financially pressed healthcare delivery market in the U.S. Across the globe, the…
The pharmaceutical industry is in the midst of profound transformation. Downward economic pressures, a tightening federal regulatory environment and changes in competition and market expectations are upending the traditional pharmaceutical commercial model. As these pressures intensify, the need for a new model becomes increasingly evident. While many manufacturers are adapting,…
